Axovant Gene Therapies
| Use attributes for filter ! | |
| Stock price | AXGT |
|---|---|
| Disclaimer | |
| Ceo | Pavan Cheruvu |
| Headquarters | Hamilton |
| Bermuda | |
| Founders | Vivek Ramaswamy |
| Founded | October 2014 |
| CFO | David Nassif |
| Parent organizations | Roivant Sciences Ltd. |
| Date of Reg. | |
| Date of Upd. | |
| ID | 2411856 |
About Axovant Gene Therapies
Axovant Gene Therapies is a clinical-stage pharmaceutical company that develops gene therapies to treat neurological disorders. The company is headquartered in New York City and is incorporated in Basel, Switzerland.
